HCW Biologics Inc. (HCWB)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Dr. Hing C. Wong Ph.D.
|
Founder, CEO, Director & Secretary | 438.66k | -- | 1954 |
|
Ms. Rebecca Byam C.P.A., M.B.A.
|
Chief Financial Officer | 309.31k | -- | 1956 |
|
Dr. Peter Rhode Ph.D.
|
Chief Scientific Officer & VP of Clinical Operations | 263.89k | -- | 1958 |
|
Ms. Nicole Valdivieso Esq., J.D.
|
Vice President of Legal Affairs | -- | -- | -- |
|
Mr. Lee D. Flowers
|
Senior Vice President of Business Development | -- | -- | 1946 |
HCW Biologics Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 35
Description
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States. Its lead products include HCW11-018b, a novel, tetra-valent T-Cell engager; HCW11-040, a multifunctional fusion molecule that is a combination of cytokines and pembrolizumab; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is in clinical trial in patients with alopecia areata diseases. The company also develops HCW9201, a fusion protein designed as a reagent to use in the production of natural killer (NK) cell-based therapies; HCW9206, a fusion protein designed as a reagent to use in the production of CAR-therapies for the treatment of infectious diseases; and HCW11-006, a multi-functional immune cell stimulator. It has a license agreement with Wugen Inc. to develop cell therapy-based treatments; and a license, research and co-development agreement with WY Biotech Co., Ltd. for its preclinical molecule. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
August 28, 2026 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
